SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

Big sell off

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Fsa888 Member Profile
 
Followed By 12
Posts 1,022
Boards Moderated 0
Alias Born 04/01/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/20/2017 5:24:19 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/20/2017 4:37:59 PM
Inovio Announces Pricing of Public Offering of Common Stock "GlobeNewswire Inc." - 7/19/2017 10:10:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/18/2017 4:15:31 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 7/18/2017 4:05:53 PM
Inovio Announces Proposed Public Offering of Common Stock "GlobeNewswire Inc." - 7/18/2017 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/14/2017 9:11:08 AM
Inovio’s DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation "GlobeNewswire Inc." - 7/6/2017 8:00:00 AM
Inovio Announces Leadership Appointments "GlobeNewswire Inc." - 6/28/2017 8:00:00 AM
Inovio Pharmaceuticals to Participate on Panel at 2017 BIO International Convention "GlobeNewswire Inc." - 6/19/2017 8:00:00 AM
Inovio Fully Enrolls 160 Subjects in Puerto Rico for Second Zika Vaccine Phase 1 Trial; Continues Leadership to Advance an Ef... "GlobeNewswire Inc." - 6/15/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/12/2017 9:57:06 AM
Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer  "GlobeNewswire Inc." - 6/8/2017 6:00:00 AM
Inovio Zika Vaccine Prevents Persistence of Virus and Damage in Male Reproductive Tract in Pre-Clinical Study "GlobeNewswire Inc." - 6/7/2017 8:00:00 AM
Inovio Announces Clinical Trial Collaboration to Evaluate a Novel T-cell Immunotherapy in Combination with a PD-L1 Checkpoint... "GlobeNewswire Inc." - 6/1/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2017 4:25:23 PM
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study "GlobeNewswire Inc." - 5/24/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/16/2017 4:07:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:35:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:29:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:18:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:15:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:15:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:14:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2017 5:14:04 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist